1[1]Mori T, Fukuoka M, Kazita K, at al. Follow-up study after intracranial percutaneous transluminal cerebral ballon angioplasity. Am J Neuroradiol, 1999, 20: 971-973.
2[2]Kantor B, Ashai K, Holmes DR Jr, et al. The experimental animal models for assessing treatment of restenosis.Cardiovasc Radiat Med, 1999, 1: 48-54.
3[3]Schwartz RS, Topol EJ, Serruys PW, et al. Artery size,neointima, and remodeling: time for some standards. J Am Coll Cardiol, 1998, 32: 2087-2094.
4[4]Sims FH. A comparison of structural features of walls of coronary arteries from 10 different species. Pathology,1989, 21: 115-124.
5[5]Kantor B, Ashai K, Holmes J, et al. The experimental animal models for assessing treatment of restenosis. Cardiovasc Radiat Med, 1999, 1: 48-54.
6[6]Bennett MR. In-stent stenosis: pathology and implications for the development of drug eluting stents. Heart, 2003,89: 218-224.
7[7]Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. Aserial intravascular ultrasound study. Circulation, 1996, 94: 1247-1254.
8[8]Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med, 1999, 340: 115-126.
9[9]Topol EJ, Serruys PW. Frontiers in interventional cardiology. Circulation, 1998, 98: 1802-1820.
10[10]Inoue T, Uchida T, Yaguchi I, et al. Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation, 2003, 107: 1757-1763.
